{
    "organizations": [],
    "uuid": "68bf5db0d9a86145b1554e2e6a6748080235459a",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-rigel-pharma-q4-loss-per-share-018/brief-rigel-pharma-q4-loss-per-share-0-18-idUSASB0C91O",
    "ord_in_thread": 0,
    "title": "BRIEF-Rigel Pharma Q4 Loss Per Share $0.18",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "March 6 (Reuters) - Rigel Pharmaceuticals Inc:\n* RIGEL ANNOUNCES FOURTH QUARTER AND YEAR END 2017 FINANCIAL RESULTS AND PROVIDES COMPANY UPDATE\n* Q4 LOSS PER SHARE $0.18 * ‍THERE WERE NO CONTRACT REVENUES FROM COLLABORATIONS IN Q4 OF 2017​ Source text for Eikon: Further company coverage:\n ",
    "published": "2018-03-07T05:13:00.000+02:00",
    "crawled": "2018-03-07T19:54:56.016+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "march",
        "reuters",
        "rigel",
        "pharmaceutical",
        "inc",
        "rigel",
        "announces",
        "fourth",
        "quarter",
        "year",
        "end",
        "financial",
        "result",
        "provides",
        "company",
        "update",
        "q4",
        "loss",
        "per",
        "share",
        "contract",
        "revenue",
        "collaboration",
        "q4",
        "source",
        "text",
        "eikon",
        "company",
        "coverage"
    ]
}